Toxicities and outcome after CD19 ‐directed chimeric antigen receptor T‐cell therapy for secondary neurolymphomatosis
American Journal of Hematology · 2024
DOI: 10.1002/ajh.27505 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Hematology, 2024. Verfasst von Leon D Kaulen und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Division of Neuro-Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Antigens, CD19, Immunotherapy, Adoptive, Neurolymphomatosis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 14 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Division of Neuro-Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.
- Department of Neurology, University Hospital Heidelberg, Heidelberg University, Heidelberg, Germany.
- Clinical Cooperation Unit Neuro-Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.
- Department of Neurosurgery, Ludwig Maximilians University (LMU), Munich, Germany.
- Department of Neurosurgery, Friedrich-Alexander-University Erlangen/Nuernberg, Erlangen, Germany.
- Department of Medicine, Hematology, and Oncology Division, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.
ORCID-Profile: Leon D Kaulen
Zitieren
APA
Kaulen, L. D., Karschnia, P., Doubrovinskaia, S., Abramson, J. S., Martinez-Lage, M., Shankar, G., Choi, B. D., Barnes, J. A., El-Jawahri, A., Hochberg, E. P., Johnson, P. C., Soumerai, J. D., Wick, W., Maus, M. V., Chen, Y. B., Frigault, M. J., & Dietrich, J. (2024). Toxicities and outcome after CD19 ‐directed chimeric antigen receptor T‐cell therapy for secondary neurolymphomatosis. American Journal of Hematology. https://doi.org/10.1002/ajh.27505
Vancouver
Kaulen LD, Karschnia P, Doubrovinskaia S, Abramson JS, Martinez-Lage M, Shankar G, et al. Toxicities and outcome after CD19 ‐directed chimeric antigen receptor T‐cell therapy for secondary neurolymphomatosis. American Journal of Hematology. 2024. doi:10.1002/ajh.27505
BibTeX
@article{Kaulen2024,
author = {Kaulen, Leon D and Karschnia, Philipp and Doubrovinskaia, Sofia and Abramson, Jeremy S and Martinez-Lage, Maria and Shankar, Ganesh and Choi, Bryan D and Barnes, Jeffrey A and El-Jawahri, Areej and Hochberg, Ephraim P and Johnson, P Connor and Soumerai, Jacob D and Wick, Wolfgang and Maus, Marcela V and Chen, Yi-Bin and Frigault, Matthew J and Dietrich, Jorg},
title = {Toxicities and outcome after CD19 ‐directed chimeric antigen receptor T‐cell therapy for secondary neurolymphomatosis},
journal = {American Journal of Hematology},
year = {2024},
doi = {10.1002/ajh.27505}
}
EUVIMED